Regulation of opioid receptors in rat sensory neurons in culture

Molecular Pharmacology

Volumn 51, Issue 4, 1997, Pages 666-673

  Chen, Joanne J ^a   Dymshitz, Julia ^a   Vasko, Michael R ^a  

^a INDIANA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DELTA OPIATE RECEPTOR; DIPRENORPHINE; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; ENKEPHALIN[2,5 DEXTRO PENICILLAMINE]; KAPPA OPIATE RECEPTOR; MU OPIATE RECEPTOR; N METHYL N [7 (1 PYRROLIDINYL) 1 OXASPIRO[4.5]DEC 8 YL]BENZENEACETAMIDE; NALOXONE;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DRUG RECEPTOR BINDING; EMBRYO; NERVE CELL CULTURE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR AFFINITY; RECEPTOR UPREGULATION; SENSORY NERVE CELL; SPINAL GANGLION;

EID: 0030945116     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.51.4.666     Document Type: Article

References (41)

1. Yaksh, T. L. Analgesic actions of intrathecal opiates in cat and primate. Brain Res. 153:205-210 (1978).
2. Cousins, M. J., and L. E. Mather. Intrathecal and epidural administration of opioids. Anesthesiology 61:276-310 (1984).
3. North, R. A. Opioid receptor types and membrane ion channels. Trends Neurol. Sci. 9:114-117 (1986).
4. Werz, M. A., and R. L. MacDonald. Opioid peptides selective for mu-and delta-opiate receptors reduce calcium-dependent action potential duration by increasing potassium conductance. Neurosci. Lett. 42:173-178 (1983).
5. Dunlap, K., and G. Fischbach. Neurotransmitters decrease the calcium conductance activated by depolarization of embryonic chick sensory neurons. J. Physiol. 317:519-535 (1981).
6. Shroeder, J. E., P. S. Fischbach, D. Zheng, and W. McCleskey. Activation of mu opiold receptors inhibits transient high and low threshold calcium currents but spares a sustained current. Neuron 6:13-20 (1991).
7. Mauborgne A., O. Lutz, J.-C. Legrand, M. Hamon, and F. Cesselin. Opposite effects of δ and μ opioid receptor agonists on the in vitro release of substance P-like material from the rat spinal cord. J. Neurochem. 48:529-534 (1987).
8. Pang, I.-H., and M. R. Vasko. Morphine and norepinephrine but not 5-hydroxytryptamine and γ-aminobutyric acid inhibit the potassium-stimulated release of substance P from rat spinal cord slices. Brain Res. 376:268-279 (1986).
9. Crain, S. M., and K-F. Shen. Opioids can evoke direct receptor-mediated excitatory effects on sensory neurons. Trends Pharmacol. Sci. 11:77-81 (1990).
10. Smart D., and D. G. Lambert. The stimulatory effects of opioids and their possible role in the development of tolerance. Trends Pharmacol. Sci. 17:264-268 (1996)
11. Shen, K. and S. M. Crain. Dual opioid modulation of the action potential duration of mouse dorsal root ganglion neurons in culture. Brain Res. 491:227-247 (1989).
12. Suarez-Roca, H., L. Abdullah, J. Zuniga, S. Madison, and W. Maixner. Multiphasic effect of morphine on the release of substance P from rat trigeminal nucleus slices. Brain Res. 579:187-194 (1992).
13. Suarez-Roca H., and W. Maixner. Activation of kappa opioid receptors by U50488H and morphine enhances the release of substance P from rat trigeminal nucleus slices. J. Pharmacol. Exp. Ther. 264:648-653 (1993).
14. Moises, H. C., K. I. Rusin, and R. L. Macdonald. μ-And κ-opioid receptors selectively reduce the same transient components of high-threshold calcium current in rat dorsal root ganglion sensory neurons. J. Neurosci. 14:5903-5916 (1994).
15. 2+ currents by a μ-opioid in a defined subset of rat sensory neurons. J. Neurosci. 13:867-873 (1993).
16. Zadina J. E., A. J. Kastin, L. M. Harrison, L.-J. Ge, and S. L. Chang. Opiate receptor changes after chronic exposure to agonists and antagonists. Ann. N. Y. Acad. Sci. 757:353-361, 1995.
17. Per, C. B., and S. H. Snyder. Opiate receptor binding enhancement by opiate administration in vivo. Biochem. Pharmacol. 25:847-853 (1976).
18. Zukin, R. S., A. Tempel, and E. L. Gardener. Opiate receptor upregulation and functional supersensitivity, in Mechanisms of Tolerance and Dependence, NIDA Research Monograph Series 54 (C. W. Sharp, ed.). U. S. Government Printing Office, Washington, D. C., 146-161 (1984).
19. Law, P. Y., D. S. Hom, and H. H. Loh. Down-regulation of opiate receptors in neuroblastoma-glioma NG108-15 hybrid cells: chloroquine promotes accumulation of tritiated enkephalin in the lysosomes. J. Biol. Chem. 259:4096-4104 (1984).
20. Baumhaker, Y., M. Gafni, O. Keren, and Y. Sarne. Selective and interactive down-regulation of μ and δ-opioid receptors in human neuroblastoma SK-N-SH cells. Mol. Pharmacol. 44:461-467 (1993).
21. Zadina, J. E., S. L. Chang, L.-J. Ge, and A. J. Kastin. Mu opiate receptor down-regulation by morphine and up-regulation by naloxone in SH-SY5Y human neuroblastoma cells. J. Pharmacol. Exp. Ther. 265:254-262 (1993).
22. Tao, P. L., P. Y. Law, and H. H. Loh. Decrease in delta and mu opioid receptor binding capacity in rat brain after chronic etorphine treatment. J. Pharmacol. Exp. Ther. 240:809-816 (1987).
23. Dingledine, R., R. J. Valentino, E. Bostock, M. E. King, and K. J. Chang. Down relation of delta but not mu opioid receptors in the hippocampal slice associated with loss of physiological response. Life Sci. 33:333-336 (1983).
24. 3H-etorphine in morphine-dependent rats. Life Sci. 31:1405-1408 (1982).
25. 3H-naloxone binding in the naive, dependent and withdrawal states. Brain Res. 360:214-223 (1985).
26. Yoburn, B. C., B. Billings, and A. Duttaroy. Opioid receptor regulation in mice. J. Pharmacol. Exp. Ther. 265:314-320 (1993).
27. Chen, J. J., J. Dymshitz, L. Yu, and M. R. Vasko. Characterization of opioid receptors in sensory neurons in culture. Neurosci. Abstr. 20:749 (1994).
28. 2 enhances bradykinin-stimulated release of neuropeptides from rat sensory neurons in culture. J. Neurosci. 14:4987-4997 (1994).
29. Bradford, M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248-254 (1976).
30. Gardener, E. L., R. S. Zukin, and M. Makman. Modulation of opiate receptor binding in striatum and amygdala by selective mesencephalic lesions. Brain Res. 194:232-239 (1980).
31. Vaysse, P. J.-J., R. S. Zukin, K. L. Fields, and J. A. Kessler. Characterization of opioid receptors in cultured neurons. J. Neurochem. 55:624-631 (1990).
32. Attali, B., and Z. Vogel. Characterization of κ opiate receptors in rat spinal cord dorsal root ganglion cocultures and their regulation by chronic opiate treatment. Brain Res. 517:182-188 (1990).
33. Raynor, K., H. Kong, Y. Chen, K. Yasuda, L. Yu, G. I. Bell, and T. Reisine. Pharmacological characterization of the cloned κ-, δ-, and μ-opioid receptors. Mol. Pharmacol. 45:330-334 (1993).
34. Arvidsson, U., M. Riedl, S. Chakrabarti, J.-H. Lee, A. H. Nakano, R. J. Dado, H. H. Loh, P.-Y. Law, M. W. Wessendorf, and R. Elde. Distribution and targeting of a μ-opioid receptor (MOR1) in brain and spinal cord. J. Neurosci. 15:3328-3341 (1995).
35. Arvidsson, U., R. J. Dado, M. Riedl, J.-H. Lee, P. Y. Law, H. H. Loh, R. Elde, and M. W. Wessendorf. Delta-opioid receptor immunoreactivity: distribution in brainstem and spinal cord and relationship to biogenic amines and enkephalin. J. Neurosci. 15:1215-1235 (1995).
36. Hiller, J. M., E. J. Simon, S. M. Crain, and E. R. Peterson. Opiate receptors in cultures of fetal mouse dorsal root ganglia (DRG) and spinal cord: predominance in DRG neurites. Brain Res. 145:396-100 (1978).
37. Tempel, A., S. M. Crain, E. R. Peterson, E. J. Simon, and R. S. Zukin. Antagonist-induced opiate receptor upregulation in cultures of fetal mouse spinal cord-ganglion explants. Dev. Brain Res. 25:287-291 (1986).
38. Werling, L. l., P. N. McMahon, and B. M. Cox. Selective changes in μ opioid receptor properties induced by chronic morphine exposure. Proc. Natl. Acad Sci. USA 86:6393-6397.
39. Lenoir, D., J. Barg, and R. Simantov. Characterization and down-regulation of opiate receptors in aggregating fetal rat brain cells. Brain Res. 304:285-290 (1984).
40. 5]enkephalin treatment Brain Res. 462:313-320 (1988).
41. Tao, P. L., H. Y. Lee, L. R. Chang, and H. H. Loh. Decrease in mu opioid receptor binding capacity in rat brain after chronic PL017 treatment. Brain Res. 526:270-275 (1990).